NO20012684D0 - Nye nukleinsyre-overföringsmidler, preparater inneholdende disse, samt deres anvendelse - Google Patents

Nye nukleinsyre-overföringsmidler, preparater inneholdende disse, samt deres anvendelse

Info

Publication number
NO20012684D0
NO20012684D0 NO20012684A NO20012684A NO20012684D0 NO 20012684 D0 NO20012684 D0 NO 20012684D0 NO 20012684 A NO20012684 A NO 20012684A NO 20012684 A NO20012684 A NO 20012684A NO 20012684 D0 NO20012684 D0 NO 20012684D0
Authority
NO
Norway
Prior art keywords
nucleic acid
compositions containing
transfer agents
acid transfer
new nucleic
Prior art date
Application number
NO20012684A
Other languages
English (en)
Other versions
NO20012684L (no
Inventor
Jean Herscovici
Hans Hofland
Christophe Jacopin
Daniel Scherman
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9815309A external-priority patent/FR2786700B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20012684D0 publication Critical patent/NO20012684D0/no
Publication of NO20012684L publication Critical patent/NO20012684L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO20012684A 1998-12-03 2001-05-31 Nye nukleinsyreoverföringsmidler, med preparater inneholdende disse, samt deres anvendelse NO20012684L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9815309A FR2786700B1 (fr) 1998-12-03 1998-12-03 Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs utilisations
US11718499P 1999-01-26 1999-01-26
PCT/FR1999/002995 WO2000032803A2 (fr) 1998-12-03 1999-12-02 Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs utilisations

Publications (2)

Publication Number Publication Date
NO20012684D0 true NO20012684D0 (no) 2001-05-31
NO20012684L NO20012684L (no) 2001-07-30

Family

ID=26234691

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012684A NO20012684L (no) 1998-12-03 2001-05-31 Nye nukleinsyreoverföringsmidler, med preparater inneholdende disse, samt deres anvendelse

Country Status (13)

Country Link
EP (1) EP1137793A2 (no)
JP (1) JP2002531468A (no)
KR (1) KR20010101116A (no)
CN (1) CN1348498A (no)
AU (1) AU772033B2 (no)
BR (1) BR9915897A (no)
CA (1) CA2353576A1 (no)
CZ (1) CZ20011909A3 (no)
HU (1) HUP0200345A3 (no)
IL (1) IL142704A0 (no)
NO (1) NO20012684L (no)
PL (1) PL348513A1 (no)
WO (1) WO2000032803A2 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805271B1 (fr) * 2000-02-18 2002-04-26 Aventis Pharma Sa Procede de preparation de polyalkylenimines fonctionnalises, compositions les contenant et leurs utilisations
JP2005080598A (ja) * 2003-09-10 2005-03-31 Japan Science & Technology Agency β−１，３−グルカン誘導体を用いるプラスミドＤＮＡの導入法
CN103820320B (zh) * 2013-06-25 2017-03-15 宁波有成生物医药科技有限公司 一种非冻型rna保护液

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4690596A (en) * 1994-12-30 1996-07-24 Chiron Viagene, Inc. Nucleic acid condensing agents with reduced immunogenicity
FR2730637B1 (fr) * 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
US5948681A (en) * 1996-08-14 1999-09-07 Children's Hospital Of Philadelphia Non-viral vehicles for use in gene transfer

Also Published As

Publication number Publication date
WO2000032803A2 (fr) 2000-06-08
KR20010101116A (ko) 2001-11-14
CA2353576A1 (fr) 2000-06-08
BR9915897A (pt) 2001-08-21
NO20012684L (no) 2001-07-30
IL142704A0 (en) 2002-03-10
AU772033B2 (en) 2004-04-08
EP1137793A2 (fr) 2001-10-04
JP2002531468A (ja) 2002-09-24
WO2000032803A3 (fr) 2000-10-12
PL348513A1 (en) 2002-06-03
CZ20011909A3 (cs) 2001-09-12
HUP0200345A2 (hu) 2002-05-29
AU1564600A (en) 2000-06-19
HUP0200345A3 (en) 2003-12-29
CN1348498A (zh) 2002-05-08

Similar Documents

Publication Publication Date Title
NO324250B1 (no) Diazabicykliske forbindelser, farmasoytiske sammensetninger omfattende disse samt deres anvendelse
NO20010013D0 (no) Svovelsubstituerte sulfonylaminokarboksylsyre N-arylamider, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene
DE1051515T1 (de) Modifizierte nuklein-säure sonden und dessen verwendungen
DE69933283D1 (de) Photoaktivierbare nukleinsäure-derivate
ATE297898T1 (de) 4-carboxamino-2-subsitutierte-1,2,3,4- tetrahydrochinoline als cetp inhibitoren
ATE277906T1 (de) 4-carboxamino-2-methyl-1,2,3,4- tetrahydrochinoline als cetp inhibitoren
DE69841895D1 (de) Nukleinsäuretestverfahren
NO20003496L (no) Nye aromatiske amider, fremgangsmÕte for fremstilling av disse, samt deres anvendelse som medisiner
DE60026508D1 (de) Verwendungen von ppar-gamma-agonisten in neutrophil-verursachten erkrankungen
DK1018337T3 (da) Chlorhexidinformuleringer, nye chlorhexidinsalte, opløsninger indeholdende sådanne samt disses anvendelse
DK1104762T3 (da) Substituerede imidazo[1,2a]aziner som selektive COX-2-inhibitorer
NO20021007L (no) Substituerte 3-fenyl-5-alkoksy-1,3,4-oksdiazol-2-oner og deres anvendelse som lipasehemmere
DE975695T1 (de) Zusammensetzungen, enthaltend gleit- und antiblockmittel
NO20012684D0 (no) Nye nukleinsyre-overföringsmidler, preparater inneholdende disse, samt deres anvendelse
NO20004648L (no) Nukleinsyreoverføringsvektorer, deres anvendelse samt preparater inneholdende vektorene
NO995833L (no) Ny landbrukskjemisk sammensetning samt kondisjoneringsmiddel
ID25990A (id) Susunan dna
NO20004780D0 (no) Nye overføringsmidler for nukleinsyrer, preparater inneholdende disse samt midlenes anvendelse
FR2781983B1 (fr) Utilisation herbicide, composition herbicide et procede herbicide l'utilisant
NO20004075D0 (no) Substituerte pyrimidin-2-yloksy-karboksylsyrederivater, fremstilling av disse og deres anvendelse som endotelin- antagonister
FI980782A0 (fi) En till epitel celler bindande protein region samt proteinet kodande DNA sekvens
NO20005683D0 (no) Ny formulering inneholdende paroxetin
FR2776669B1 (fr) Vecteurs de transfert d'acides nucleiques, compositions les contenant, et leurs utilisations
DK0956283T3 (da) Substituerede phenyltriazolin(thi)oner samt deres anvendelse som herbicider
BR9810558B1 (pt) composição quìmica agrìcola em suspensão aquosa.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application